Drug Research
Moderna to Acquire OriCiro Genomics for $85M
Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch.
Through the acquisition, Moderna will obtain OriCiro’s tools for cell-free synthesis and amplification of plasmid...
Drug Research
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, NY
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics.
The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio. As part...
Industry Reports
JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores
JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals Ltd., to acquire the entire Razel (Rosuvastatin) franchise for the India and Nepal region for a whopping Rs. 313.7 crores....
Industry Reports
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022, as a result of growing generic competition and a decline in demand for...
Industry Reports
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay Exhibition Centre, Mumbai. The event had a grand opening in the presence of key dignitaries Mr. K. G. Ananthakrishnan, Director General – OPPI, Mr....
Industry Reports
Vetter publishes first sustainability report
Vetter, a global leading Contract Development and Manufacturing Organization (CDMO), has published its first sustainability report. The report underpins the company commitment to sustainable action and covers three areas: Ecological Responsibility, Sustainable Economy, and Social Engagement. In doing so,...
Industry Reports
Dr. Reddys Says Russia Sales Booming As Big Pharma Retreats
While many western biopharma businesses have shied away from Russia since its invasion of Ukraine, some of those in India have stepped in to fill the hole by providing the Kremlin with medical supplies. Dr. Reddy's Laboratories has been...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
